Principles and Application of Immunotherapy in Cancer

Event Overview

Join our expert faculty for this exclusive interactive teleconference and Webcast at your practice on the increasing role of immunotherapy for patients with melanoma or lung cancer. Topics will include tumor–immune system interaction, therapeutic strategies to enhance the immune response, current clinical efficacy and safety experience with immunotherapy, and key ongoing clinical trials in either melanoma or lung cancer.

Don’t miss this opportunity to host a 1-hour CME workshop via private Webcast on cancer integrating immunotherapy into the treatment of NSCLC or melanoma for your practice. Call 866.690.9902 or email registration@clinicaloptions.com.

Agenda

Agenda
Topic 1: Principles and Application of Immunotherapy in Melanoma

Welcome and Introduction

Melanoma and the Immune System
    • Defining the role of the immune system in cancer
    • Tumor escape from immune surveillance
    • Harnessing the immune system as a treatment strategy for melanoma
Current Immunotherapy for Melanoma
    • Efficacy and safety of currently approved agents
    • Sequencing of immunotherapy for BRAF wild-type and BRAF-mutant melanoma
    • Managing potential adverse events associated with immunotherapy
Novel Agents and Immunotherapy Combinations

Live Question and Answer Session via Teleconference/Webcast


Topic 2: Principles and Application of Immunotherapy in Lung Cancer

Welcome and Introduction

Lung Cancer and the Immune System
    • Defining the role of the immune system in cancer
    • Tumor escape from immune surveillance
    • Harnessing the immune system as a treatment strategy for lung cancer
Incorporating Immunotherapeutic Agents in Lung Cancer
    • Efficacy and safety of agents in development
    • Selecting patients with lung cancer that might benefit from immunotherapy
    • Managing potential adverse events associated with immunotherapy
Educating Patients About Immunotherapy

Live Question and Answer Session via Teleconference/Webcast